Elevated PD-L1 and HER2 expression on aneuploid carcinoma cells in malignant ascites accelerate stumor cell immune evasion in gastrointestinal cancer patients

被引：0
|
作者：
Chen, Yang [1 ]
Qi, Changsong [1 ]
Yuan, JiaJia [1 ]
Liu, Dan [1 ]
Peng, Zhi [1 ]
Zhang, Xiaotian [1 ]
Li, Jian [1 ]
Lin, Pin Peter [2 ]
Li, Yilin [1 ]
Shen, Lin [1 ]
机构：
[1] Peking Univ, Canc Hosp, Beijing, Peoples R China
[2] Cytelligen, San Diego, CA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5381
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5381
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Applicability and interpretation of HER2/Neu & PD-L1 stains in gastrointestinal tract tumours
    Das, Prasenjit
    Mehra, Lalita
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (05) : 2 - 3
  • [22] Relationship between PD-L1 Expression and EGFR/HER2 Signaling in Non-Small-Cell Lung Cancer
    Okita, R.
    Maeda, A.
    Shimizu, K.
    Nojima, Y.
    Saisho, S.
    Nakata, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2109 - S2109
  • [23] Implications of PD-L1 expression on the immune microenvironment in HER2-positive gastric cancer
    Chen, Yang
    Jia, Keren
    Chong, Xiaoyi
    Xie, Yi
    Jiang, Lei
    Peng, Haoxin
    Liu, Dan
    Yuan, Jiajia
    Li, Yanyan
    Feng, Xujiao
    Sun, Yu
    Li, Jian
    Zhang, Xiaotian
    Shen, Lin
    MOLECULAR CANCER, 2024, 23 (01)
  • [24] PD-1/PD-L1 expression in colorectal cancer and its implications for apoptosis and tumor immune evasion
    Gasser, Martin
    Grimm, Martin
    Nichiporuk, Ekaterina
    Bueter, Marco
    Lutz, Jens
    Lebedeva, Tatiana
    Koenigshausen, Matthias
    Thalheimer, Andreas
    Thiede, Arnulf
    Heemann, Uwe
    Meyer, Detlef
    Waaga-Gasser, Ana Maria
    CANCER RESEARCH, 2006, 66 (08)
  • [25] Clinicopathological Characteristics and Prognostic Value of HER2, PD-L1 and MSI Expression in Curative Resectable Gastric Cancer Patients
    Pereira, M. A.
    Ramos, M. F.
    Faraj, S. F.
    Dias, A. R.
    Cirqueira, C. D.
    Charruf, A. Z.
    Perrotta, F. S.
    Mello, E. S.
    Zilberstein, B.
    Cecconello, I.
    Yagi, O. K.
    Alves, V. A.
    Junior, U. R.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S190 - S190
  • [26] LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression
    Rongshou Wu
    Weiwei Liu
    Qingping Yang
    Jingling Zhang
    Ping Hou
    Jianghui Xiong
    Linquan Wu
    Enliang Li
    Scientific Reports, 13
  • [27] LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression
    Wu, Rongshou
    Liu, Weiwei
    Yang, Qingping
    Zhang, Jingling
    Hou, Ping
    Xiong, Jianghui
    Wu, Linquan
    Li, Enliang
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [28] Dickkopf-1 drives tumor immune evasion by inducing PD-L1 expression in hepatocellular carcinoma
    Yang, Ruo-Han
    Qin, Jia
    Cao, Jin-Lan
    Zhang, Ming -Zhu
    Li, Ying-Ying
    Wang, Meng-Qing
    Fang, Dong
    Xie, Song-Qiang
    BIOCHEMICAL PHARMACOLOGY, 2023, 208
  • [29] The Immune Microenvironment of HER2 Positive Breast Carcinomas; CTLA-4 Expression and the PD-1/PD-L1 Axis
    Rosen, Lauren
    Novo, Jorge
    Ubago, Julianne M.
    Pincus, Jennifer
    Blanco, Luis
    Siziopikou, K. P.
    MODERN PATHOLOGY, 2018, 31 : 100 - 100
  • [30] The Immune Microenvironment of HER2 Positive Breast Carcinomas; CTLA-4 Expression and the PD-1/PD-L1 Axis
    Rosen, Lauren
    Novo, Jorge
    Ubago, Julianne M.
    Pincus, Jennifer
    Blanco, Luis
    Siziopikou, K. P.
    LABORATORY INVESTIGATION, 2018, 98 : 100 - 100
12345